Charosetta
The drug may be prescribed to nursing mothers, as well as women for whom estrogens are contraindicated.
It should be remembered that contraceptive effectiveness may decrease if the interval between taking 2 tablets is more than 36 hours. If taking the next tablet is delayed by less than 12 hours, you should take the tablet as soon as the woman remembers and take subsequent tablets at the usual time. If taking the next pill is delayed by more than 12 hours, you should adhere to the above rules for taking pills, additionally using barrier methods of contraception over the next 7 days. If taking pills was missed in 1 week of their use and there was sexual intercourse within 1 week preceding the missed pills, possible pregnancy should be excluded.
If vomiting occurs within 3-4 hours after taking the drug, absorption of the drug may be incomplete and recommendations regarding skipping the next dose of the drug should be used. If a woman does not want to change her usual dosing regimen, she needs to take an additional tablet from another package.
While taking oral contraceptives, the risk of developing breast cancer increases with age (does not depend on the duration of taking oral contraceptives, but depends on the age of the woman).
Although gestagens can affect peripheral insulin resistance and glucose tolerance, there is no evidence that dosage adjustments are required in patients with diabetes mellitus, however, women with diabetes mellitus should be under medical supervision throughout the entire treatment period.
If you have amenorrhea and pain while taking the drug, you should be aware of a potential ectopic pregnancy.
Women with a predisposition to chloasma should avoid prolonged sun exposure or exposure to UV radiation.
Despite regular use of the drug, irregular bleeding is possible. If bleeding is quite frequent and irregular, it is necessary to decide on the appointment of another contraceptive. If the above symptoms continue to occur after discontinuation of the drug, organic pathology should be excluded.
When taking low-dose hormonal contraceptives, occasionally the follicles may become larger than normal in size. In most cases, they disappear on their own, sometimes there is mild pain in the lower abdomen, and occasionally surgical intervention is required.
Large-scale epidemiological studies have not revealed a teratogenic effect when taking oral contraceptives in early pregnancy, nor an increased risk of having children with anomalies.
When taking rifampicin, a barrier contraceptive method should be used throughout the course of treatment and for 28 days after discontinuation of this drug.
Women taking drugs that induce liver enzymes for a long period of time are advised to stop taking the drug and use non-hormonal methods of contraception.
There was no evidence of any effect of the drug on the ability to drive a car or use other mechanisms.
Contraindications
Contraceptive pills Charozetta are contraindicated for use when:
- Established or suspected pregnancy;
- The presence of venous thromboembolism, including deep vein thrombosis of the leg and pulmonary embolism. Also, the medication is contraindicated if there is a history of these diseases;
- Severe liver diseases. Taking Charozetta can be started only after normalization of liver function tests;
- Liver failure;
- Established or suspected malignant hormone-dependent tumors;
- Bleeding from the vagina of varying severity of unknown etiology;
- Lactose intolerance;
- Hypersensitivity to the active (desogestrel) or auxiliary components included in Charozette.
If one of the described conditions develops while taking Charozetta, the drug should be discontinued before consulting a doctor.
Take Charozette with extreme caution according to the instructions:
- If antihypertensive therapy is ineffective;
- Against the background of persistent hypertension, which develops while taking the medication;
- Against the background of prolonged immobilization, which is associated with illness or recent surgery;
- Against the background of thromboembolic disorders, including disorders recorded in the anamnesis, since the use of the drug may contribute to the development of relapse;
- With chloasma;
- For liver cancer.
Indications for use
The contraceptive drug Charozetta is intended to prevent unwanted pregnancy.
However, its effectiveness has also been proven for endometriosis, which makes it possible to use it for this disease.
Oral Charozette tablets have also been found to slow the growth and even reduce the size of uterine fibroids . But, the result is only possible when the diameter of the formation is no more than 2.5 cm .
Photo gallery of testimony:
Preventing Pregnancy
Endometriosis
Uterine fibroids
Analogues substitutes
Oral tablets can be replaced with the following medications:
- Lactinet is produced in tablet form based on desogestrel. (Hungary).
- Eskinor-F is available in levonorgestrel-based tablets. Manufacturer: Famy Care Limited (India).
- Microlute is produced in tablets based on levonorgestrel. (Germany).
- Exluton is produced in the form of tablets based on linestrenol. (Netherlands).
Photos of substitutes:
Lactinet
Microlute
Eskinor-F
Exluton
Drug interactions
Special studies on the interaction of the contraceptive drug Charozetta with other medications have not been carried out.
In practice, it has been found that the weakening of the contraceptive effect of an oral drug can be caused by:
- Hydantoins;
- Carbamazepine;
- Oxcarbazepine;
- Troglitazone;
- Griseofulvin;
- Barbiturates;
- Rifampicin;
- Rifabutin;
- Felbamate;
- Activated carbon.
Photos of medicines:
Carbamazepine
Troglitazone
Griseofulvin
Rifampicin
Rifabutin
Felbamate
Activated carbon
Oxcarbazepine
Liver enzyme inducers are not recommended for use together with the contraceptive drug Charozetta.
Similar drugs:
- Pradzhisan Capsule
- Progestogel Gel for external use
- Progesterone Solution for injection
- Visanne Oral tablets
- Medroxyprogesterone acetate Substance-powder
- Postinor Oral tablets
- Lactinette Oral tablets
- Turinal Oral tablets
- Jazz (Yaz) Oral tablets
- Exluton Oral tablets
** The Drug Directory is intended for informational purposes only. For more complete information, please refer to the manufacturer's instructions. Do not self-medicate; Before starting to use Charozetta, you should consult a doctor. EUROLAB is not responsible for the consequences caused by the use of information posted on the portal. Any information on the site does not replace medical advice and cannot serve as a guarantee of the positive effect of the drug.
Are you interested in the drug Charozetta? Do you want to know more detailed information or do you need a doctor's examination? Or do you need an inspection? You can make an appointment with a doctor - the Euro lab is always at your service! The best doctors will examine you, advise you, provide the necessary assistance and make a diagnosis. You can also call a doctor at home . Euro lab clinic is open for you around the clock.
** Attention! The information presented in this medication guide is intended for medical professionals and should not be used as a basis for self-medication. The description of the drug Charozetta is provided for informational purposes and is not intended for prescribing treatment without the participation of a doctor. Patients need to consult a specialist!
If you are interested in any other drugs and medications, their descriptions and instructions for use, information about the composition and form of release, indications for use and side effects, methods of use, prices and reviews of drugs, or you have any other questions and suggestions - write to us, we will definitely try to help you.
Reviews from doctors
Stefanova Anna Viktorovna, gynecologist:
“Charozette tablets have one advantage - it can be used by women during breastfeeding. I often prescribe it to these women. Without fear for the health and condition of the baby.”
Avdeev Igor Vladimirovich, gynecologist:
“I often prescribe oral contraceptives to my patients. A drug like Charozetta is quite effective. Regarding adverse reactions, it depends on the individual characteristics of each woman. But if something happens, you should definitely come to your gynecologist and discuss all questions in detail with him.”
Composition and release form
The contraceptive drug Charozetta is available in the form of white tablets.
The main active ingredient is desogestrel, the amount of which in one tablet is 0.075 mg
The manufacturer is located in the Netherlands: ORGANON NV
The composition of Charozetta oral tablets is also filled with additional substances:
- Colloidal silicon ahydride;
- α-tocopherol;
- Lactose monohydrate;
- Corn starch;
- Povidone;
- Stearic acid;
- Hypromellose;
- Macrogol-400;
- Titanium dioxide.
